13 years ago, I sat down with Doug Wolens to talk about a word almost no one was using: the singularity.
Doug was a lawyer who walked away from the courtroom to make films. His documentary, The Singularity, did something rare. It refused to cheerlead. It asked questions instead.
One thing he said has stayed with me ever since. Science is a means, not an end. It does not deliver a scientific destination. It delivers a humanistic one.
That distinction matters more now than it did in 2013.
Back then, machine intelligence surpassing human intelligence was a thought experiment. Today, it is a product roadmap. We used to argue about whether it would happen. Now we argue about what to do while it does.
But the sharpest question in Doug’s film was never about the machines. It was about us.
Osteoporosis is a silent disease where bone loss develops gradually before fractures occur. Current clinical screening recommendations mainly focus on older women and selected high-risk groups, leaving some men, younger adults, and individuals with normal body weight completely outside routine screening pathways.
To close this care gap, researchers from St. Paul’s Hospital and National Taiwan University have demonstrated how AI can leverage routine chest X-rays to detect asymptomatic bone loss, closing critical gaps in screening healthy Asian populations. Their paper is published in the journal npj Digital Medicine.
Strikingly, the study found that more than half of the confirmed abnormal bone-density cases occurred in people with a normal body mass index (BMI). This reveals a severe diagnostic blind spot in conventional, guideline-based screening. By relying strictly on traditional criteria, health care systems routinely overlook healthy-weight individuals, younger adults, and men who are secretly losing bone density but remain completely off the clinical radar.
By Chuck Brooks, president of Brooks Consulting International and one of Executive Mosaic’s GovCon Experts
We have now transitioned from the age of digital dangers to an era of complete systemic vulnerability. The data clearly demonstrates that cyber threats are no longer sporadic; they represent a persistent, sophisticated phenomenon. Hackers are now utilizing autonomous adversaries rather than merely sophisticated tools.
Recent industry data obtained in early 2026 indicates a vertical trajectory, revealing that global AI-driven cyber incidents have surged by an astonishing 72 percent year-over-year. A 72 percent surge is not just growth; it’s systemic acceleration.
Quantum computing was once considered a distant scientific project that could revolutionize computing. That discussion has shifted drastically today. Quantum technologies have progressed beyond lab trials and theory. Emerging quantum capabilities include commercial quantum platforms, quantum networking projects, quantum sensor advancements, and powerful quantum processors.
Advances in recent years suggest we are entering the Quantum Frontier Era. National security, science, economic competitiveness, and cybersecurity will all feel the impact. The quantum age has begun. It’s started.
Because glucosamine is widely available and frequently used by older adults to support joint health, the researchers wanted to determine whether it could influence Alzheimer’s disease and related dementias (ADRD).
Working with collaborators Yi Guo, Ph.D., and Jiang Bian, Ph.D., the team used artificial intelligence to analyze deidentified UF Health records collected between 2012 and 2024. They focused on patients diagnosed with either ADRD or mild cognitive impairment (MCI).
Among those patients, researchers found that glucosamine use was relatively common. A total of 1,896 patients with ADRD and 2,750 patients with MCI reported taking the supplement, representing about 8% of each group.
